Ad
AUPH - Aurinia Pharmaceuticals Inc Stock Trading
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Five abstracts underscore the long-term safety and efficacy of voclosporin, including in Latino patients and patients with Class V lupus nephritis Data presentation on pre-clinical asset AUR200 reinforces Aurinia’s commitment to autoimmune disease Aurinia Phar...
-
Approval follows the positive opinion granted by European Committee for Medicinal Products for Human Use (CHMP) in July 2022 LUPKYNIS is the first oral medicine approved in both the U.S. and Europe for the treatment of adults living with active lupus nephritis Approval...
-
Shares of commercial-stage autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) raced higher in early action Thursday morning, rising as much as 15.7%. However, Aurinia's shares have given back most of these gains as the session has progressed. As of 10:58 a.m. E...